Whitefort Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Whitefort Capital Management LP
CRD #288534
SEC #801-116942
CIK #0001884931
AUM 1,051.1 M (2026-03-27)
Employees 11 (55% Investors, 0% Brokers)
Fees
Minimum
Phone212-259-4370
Address12 E 49th Street
New York, NY 10017
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
110088066044022002010201520212027
Fees and Compensation — Form ADV Part 2A (3/27/2026) [Brochure]
Item 5: Fees and Compensation

Fees and compensation are described in the advisory agreements Whitefort entered into with
each Fund. All of the investors in the Funds are “qualified purchasers” (as defined in Section
2(a)(51) of the Investment Company Act of 1940, as amended (the “1940 Act”)).

For the Whitefort Fund, Whitefort receives management fees based on a percentage of the assets
under management, as well as a performance allocation based on a percentage of the aggregate
net gains (including current income and realized and unrealized gains and losses, determined
after all Fund expenses and management fees). Whitefort has the right to reduce, waive, assign,
participate or otherwise share the management fee, as applicable. Once paid, the management
fee will not be refundable.

An investor admitted into or withdrawing, either partially or in whole, from the Whitefort Fund
other than on the first day of a calendar quarter is subject to a prorated management fee.

The General Partners receive a performance-based allocation derived from the net appreciation
of each investor’s capital account as described fully in the Funds’ governing documents.

Management fees and performance allocations are deducted from the Funds’ accounts by the
Funds’ administrator. Management fees are paid quarterly in advance on the first day of each

calendar quarter, whereas performance-based allocations are made at the end of each fiscal year
and upon a limited partner’s withdrawal of all or any portion of its capital account.

Under its respective governing documents, each Fund will bear or reimburse the Firm and/or
the General Partners for advancing, the Fund’s operating and other expenses. The Firm and/or
the General Partners may, in their discretion, waive their right to be reimbursed for any of the
following expenses for any period of time.

Expenses borne by the Funds, or reimbursed to the Firm and/or the General Partners, shall
include, but not be limited to: (1) expenses related to investment transactions and positions for
the Funds’ account, including brokerage commissions and custody charges, clearing and
settlement charges, interest and commitment fees on loans and debit balances, costs of
borrowing securities to be sold short; (2) third party operations, accounting and portfolio and
trading-related software and system costs; (3) research and market data fees, expenses and
materials (including Bloomberg services and terminal, Debtwire service, Reorg Research
service, Covenant Review service and other subscriptions to news and quotation services and
print publications, computer hardware, data feed for portfolio securities, data and software used
for research (and any exchange fees related thereto), and travel expenses (including
transportation and lodging) relating to investment research and monitoring, due diligence and
execution); (4) trustees’ fees; (5) proxy solicitation firm fees; (6) public relations firm fees
related to the Funds’ investment activities; (7) fees and expenses incurred in connection with
the Funds’ risk management systems and processes (including software); (8) costs of any
outside appraisers, sub-advisors, accountants, auditors, attorneys, independent pricing services
or other experts or consultants engaged by the Firm, the General Partners and/or the Funds to
serve the needs of the Funds; (9) the fees, costs and expenses of the Funds’ governance
committees; (10) fees and expenses of any Fund’s board of directors (including, without
limitation, expenses related to the organization and conduct of directors’ and shareholders’
meetings (including, without limitation, travel, lodging and meal expenses) and director
registration fees); (11) fees and expenses of the Funds’ administrator (such as portfolio and
investor accounting, middle office, tax and financial reporting and investor servicing costs);
(12) costs and expenses in connection with communications to investors, including preparation
and distribution to investors of reporting materials; (13) bank charges; (14) costs of insurance,
including, without limitation, directors and officers liability insurance, errors and omission
insurance, and cybersecurity insurance and liability insurance covering the Funds, the General
Partners, the Firm and the members, partners, officers, employees and agents of any of them,
and each member of the governance committee (in each case, even if such insurance covers
conduct for which indemnity would not be available from the Funds); (15) organizational
expenses and expenses incurred in connection with the offering and sale of shares and interests,
including, without limitation, the preparation of the Funds’ governing documents, subscription
agreement, registered office fees, fees and expenses of the Firm incurred in connection with
“world sky” matters and private placement regimes, including the European Alternative
Investment Fund Managers Directive, and Form D and blue sky and similar fees and expenses,
and expenses incurred in connection with negotiating and complying with provisions of the
Income Sharing Agreement and any other side letter agreement with investors; (16) all legal
fees and costs, including legal expenses arising in connection with the Funds’ investing
activities (whether or not materialized), legal expenses relating to the formation and
organization of the Funds and legal expenses and costs (including settlement costs) arising in
connection with any litigation or regulatory investigation instituted against the Funds, the Firm
and/or the General Partners regarding the affairs of the Funds; (17) the Funds’, the General
Partners’ and the Firm’s costs and expenses relating to regulatory and statutory filings (such as
Cayman Islands regulatory fees, charges and expenses with respect to the Funds, the Funds’
directors, the General Partners and the Firm’s, filings for the Foreign Account Tax Compliance
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/27/2026) [Brochure]
Item 7: Types of Clients

Whitefort provides advisory services to the Funds, which are private investment funds.
Investors in the Funds are generally high net worth individuals and institutional investors that
qualify as “accredited investors” (as defined in Rule 501 under the Securities Act of 1933, as

amended) and “qualified purchasers” (as defined under the 1940 Act). The subscription
minimums for each Fund are disclosed in their respective governing documents which are
provided to investors or prospective investors for each Fund.

The Firm, the Managing Members, and certain related parties have entered into an agreement
with a certain investor (the "Strategic Investor"), whereby the Strategic Investor has made a
significant investment in the Whitefort Fund. The Strategic Investor contributed a significant
sum of capital to the Whitefort Fund, on certain terms not offered to other investors. The
Strategic Investor has no rights with respect to the operation of the Firm, the Funds or the
General Partners.
Sector Form 13F Holdings Value ($M)
Tekmira Pharmaceuticals Corp 67.2
Roivant Sciences Ltd 39.3
YY Inc 30.7
Flame Acquisition Corp 25.5
Genworth Financial Inc 25.4
Twin River Worldwide Holdings Inc 23.2
Avista Public Acquisition Corp II 22.3
New Media Investment Group Inc 22.0
Cadiz Inc 19.6
Surgery Partners Inc 10.9
View All
Holdings by Sector ($M)
4003202401608002020202220242027
Type Form D Funds Date Sold AUM
PE WLSO Investments LP [2019-06-11] 49.8 M 7.5 M
Filed 2020-03-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF Whitefort Capital Master Fund LP [2017-05-30] 75.0 M 1,051.1 M
Filed 2025-04-08 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 1,051.1
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 1,051.1
By Discretionary
Discretionary 3 1,051.1
Non-Discretionary 0 0.0
Total 3 1,051.1
By Non-United States Persons
Non-United States Persons 622.4
United States Persons 428.7
Total 3 1,051.1
Form D Directors Role # Filings # Firms 2011 - 2026
Joseph Kaplan Executive Officer 22 3
David Salanic Executive Officer 10 3
Whitefort Capital Management LP Promoter 3 2
Whitefort Capital GP LLC Promoter 2 2
EDGAR Form CIK 2011 - 2026
13F-HR [0001884931]
SC 13D [0001884931]
SC 13G [0001884931]
Form 13D/13G Filer Form 13D/13G Subject Filed
Whitefort Capital Management LP Bally's Corp [2026-03-09]
Whitefort Capital Management LP Omniab Inc [2025-06-06]
Whitefort Capital Management LP Innovate Corp [2025-01-24]
Whitefort Capital Management LP Cadiz Inc [2024-11-12]
Whitefort Capital Management LP Arbutus Biopharma Corp [2024-05-09]
Whitefort Capital Management LP Arbutus Biopharma Corp [2023-09-11]
Whitefort Capital Management LP Global Ship Lease Inc [2022-12-16]
Whitefort Capital Management LP Central & Eastern Europe Fund Inc [2022-11-10]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI549300ZQM8PQN8GOTL37
Comparable Firms State AUM
5AM Venture Management LLC
CA 1,084.3 M
FJ Capital Management LLC
VA 1,079.8 M
Forester Capital LLC
CT 1,070.8 M
Caltius Capital Management LP
CA 1,064.9 M
Avidity Partners Management LP
TX 1,059.2 M
Preston Capital LLC
CA 1,054.6 M
1543 Capital LP
CT 1,038.0 M
Bay Point Advisors LLC
GA 1,034.0 M
Theorem Partners LLC
NY 1,032.4 M
Isometry Capital LLC
NY 1,012.7 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com